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Abstract
Introduction: Leiomyosarcomas are rare tumors. The most common site for head and neck leiomyosarcomas is
the oral cavity, followed by sinonasal tract and skin. Subcutaneous leiomyosarcomas are thought to arise from
small to medium-sized blood vessels in the subcutaneous tissue.
Case Presentation: A 67-year-old female patient underwent excision of a slow growing neck mass of the left
posterior neck triangle after a thorough clinical and laboratory examination. The lesion was located in the subcutis
and fine needle aspiration biopsy revealed malignant features. Histology revealed subcutaneous leiomyosarcoma
and the patient is free from local recurrence and distant metastases 3 years after wide excision of the lesion.
Conclusions: The primary modality of therapy of subcutaneous leiomyosarcoma is surgery, adjuvant radiotherapy
or chemotherapy may be used for control of local recurrence, in case of positive surgical margins, high-grade or
large tumors.
Introduction
Soft tissue sarcomas compromise approximately 0.7% of
all malignant neoplasms, and leiomyosarcomas (LMSs)
have been reported to account for 3-7% of soft tissue
sarcomas [1]. LMSs are divided into those involving
deep soft tissues sites as the retroperitoneum and those
involving peripheral soft tissue sites. These peripheral
soft tissue LMSs arising in either the dermis or the sub-
cutis and together are referred to as superficial LMSs.
Superficial LMSs arising in the dermis with or without
extension into the subcutis are referred to as cutaneous
LMSs while tumors arising in the subcutis are termed
subcutaneous LMSs [2].
Subcutaneous LMS is thought to arise from small to
medium-sized blood vessels in the subcutaneous tissue
[3]. It is associated with higher rates of local recurrence,
metastasis and death from disease, compared with
lesions arising from cutaneous structures [3]. It usually
presents as a painless or tender solitary subcutaneous
nodule or group of nodules and has been reported to
arise on the head and neck, back, thigh and beneath
radiation dermatitis [4,5]. In this article, we report the
case of a patient with a subcutaneous LMS located in
the skin on the left side of the neck managed with wide
surgical excision.
Case report
A 67-year-old Greek woman, presented in the General
Hospital of Volos with a painless neck mass on the left
(Fig. 1). No previous operations were recorded in
patient’s medical history. She reported that the lesion
appeared in the last year and had a slow growth. Fine
needle aspiration biopsy (FNA) of the lesion revealed a
small amount of inflammatory cells mainly lymphocytes
and several neoplastic cells with malignant features
advocating undifferentiating carcinoma. These cells were
either scattered or aggregated with large, hyperdense
nuclei, nuclear membrane grooves and several abnormal
mitoses. Several neoplastic cells were spindle shaped
with solid cytoplasm and multiple nuclei. Computed
tomography with contrast of the neck region revealed a
bi-lobe lesion of 3.2 × 2 × 4 cm dimensions with per-
ipheral enhancement and hypodense necrotic center in
the subcutaneous tissue of the posterior neck triangle
with no involvement of the deeper muscle tissue (Fig.
2). After a thorough clinical examination, including
endoscopy of the nasopharynx, larynx, and hypopharynx,
and with no signs of metastatic disease, the lesion was
excised under topical anesthesia. * Correspondence: skoulakis@otenet.gr
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mesenchymal neoplasm consisting of perpendicularly
arranged fascicles of spindle cells with eosinophilic
fibrillary cytoplasm, scattered pleomorphic nuclei and
irregular mitosis with a rate of 6 to 8 per 10 high-
power-fields (Fig. 3). The lesion was localized in the
subcutaneous tissue, while medially it was in contact
with striated muscle without infiltrating it. On immuno-
histochemical staining, the tumor expressed focal
smooth muscle actin (a-SMA) and vimentin, while a
small number of tumor cells were also weakly positive
to HHF-35, desmin and S-100 stains. According to the
histopathology and immunohistochemistry, the final
diagnosis was subcutaneous LMS of the neck and the
specimen’s surgical margins were negative. Brain mag-
netic resonance as well as computed tomography of
lungs and abdomen did not reveal any distant metastatic
disease. Due to the local aggressive nature of the disease,
the patient underwent a further wider local excision of
the dermis and subcutaneous tissue of approximately 3
cm around the first excision and the defect was recon-
structed with a regional rotational flap. No adjuvant
therapy was recommended and three years postopera-
tively the patient is without signs of local recurrence or
metastasis.
Discussion
Soft tissue sarcomas are relatively rare neoplasms that
may arise in any anatomic region. Occurrence in the
head and neck accounts for less than 1% of all malig-
nant tumors in this site [5]. Sarcomas of the head and
neck most commonly present as painless submucosal or
subcutaneous mass of uncertain duration. Superficial
LMS is presented in middle age with a median age of
diagnosis 45 to 50 years of age. A male-to-female predo-
minance is reported of 2:1 to 3:1. Superficial leiomyosar-
comas occur on the lower extremities (50-70%), the
upper extremities (20-30%), the trunk (10-15%), and
head and neck (1-5%) [3]. The most common site for
head and neck LMSs is the oral cavity (22%), followed
by sinonasal tract (19%) and skin (17%) [6]. Although
subcutaneous LMS is thought to arise from small to
medium-sized blood vessels in the subcutaneous tissue,
Figure 1 The lesion on the left side of the patient’sn e c k
before excision.
Figure 2 Axial CT scan with contrast of the neck showing the
lesion with peripheral enhancement and hypodense necrotic
center in the subcutaneous tissue of the posterior neck
triangle.
Figure 3 Histology revealing perpendicularly arranged fascicles
of spindle cells with eosinophilic fibrillary cytoplasm, scattered
pleomorphic nuclei and irregular mitosis (Hematoxylin-Eosin
×200).
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cells or it may be metastatic from other body regions,
mainly as a late event associated with systemic metasta-
sis and poor prognosis [6]. The low incidence of LMSs
in the head and neck region is attributed to the scarcity
of smooth muscle in this area which is limited to vessel
walls, erector pili muscle of the hair follicles, esophagus
and the posterior wall of the trachea [6,7]. Subcutaneous
LMS may be covered with intact skin or may sometimes
invade the overlying dermis. Management of these
lesions should begin with a thorough clinical examina-
tion. Imaging studies, computed tomography (CT) and/
or magnetic resonance imaging (MRI), usually follow
the clinical evaluation and can be used individually or in
combination. MRI has the advantage of delineating vas-
cular involvement and is valuable for lesions located in
the neck and parapharyngeal region. In case of a neck
mass the appropriate work-up has to exclude the possi-
bility of metastatic carcinoma or lymphoma. FNA in
experienced hands can rule out metastatic squamous
cell carcinoma, thyroid carcinoma or lymphoma. FNA
results may also be suspected for soft tissue sarcoma,
although it is difficult to diagnose a particular subtype
of sarcoma. False negative results may be attributable to
necrotic center of the tumor [5,7]. Subcutaneous LMS
shows a higher primary growth rate than cutaneous
LMS and a rate of local recurrence of 40 to 60%. Distant
metastases affect commonly the lungs, bones, central
nervous system and liver in 30 to 60% of patients [8].
Differential diagnosis includes myofibrosarcoma, fibro-
sarcoma, malignant nerve sheath tumor, malignant
fibrous histiocytoma and rhabdomyosarcoma and can be
made only after detailed histopathologic analysis [9].
Treatment of subcutaneous LMS is dictated by stage,
location, size and patient age. The primary modality of
therapy is surgery which must be designed to be cura-
tive. A wide excision with 3-5 cm lateral margins and a
depth that includes subcutaneous tissue and fascia is
recommended. Lymph node metastasis in head and
neck sarcomas account for 10 to 15% of cases and neck
dissection is not required for staging or treatment [5,6].
R a d i o t h e r a p yh a sb e e nu s e da sa na d j u v a n tt h e r a p yi n
order to minimize the incidence of local recurrence
although sarcomas are considerable radio-resistant. Two
indications for postoperative radiotherapy exist: 1) high-
grade lesions and/or positive surgical margins, and 2)
lesions larger than 5 cm and/or recurrence [10]. The
outcome of chemotherapy in soft tissue sarcomas in
head and neck is similar with that of the extremities,
with adriamycin being the most important chemothera-
peutic agent [7]. Although adjuvant therapy in LMSs is
still controversial as no sufficient statistical evidence
exists regarding their efficacy, chemotherapy combined
with radiotherapy seems to improve local control of the
disease especially when wide resection cannot be
achieved [7,11]. A 42% recurrence rate for oral cavity
and skin lesions has been reported [6]. Although tumor
location and depth affect the recurrence rate and meta-
static risk, the mitotic activity seems not to have a simi-
lar effect [11]. Head and neck sarcomas show worse
survival outcomes compared with sarcomas of the extre-
mities, with a 5-year survival rate between 49 and 55%
[5]. Since lymph node metastasis is uncommon, the sur-
vival outcome depends mainly on local recurrence and
distant metastasis control. Patients should be observed
for a minimum of 5 years after surgery, as recurrence
rates are variable, depending on the site of the tumor.
Most of the patients present local recurrence within 2
years after initial management and those with recurrent
disease are at risk for developing distant metastasis [8].
Conclusion
Management of a neck mass may surprisingly reveal a
rare lesion such as subcutaneous leiomyosarcoma. A
thorough clinical and laboratory examination is essential
in order to achieve fast diagnosis and curative excision
of this aggressive tumor. The primary modality of ther-
apy of subcutaneous LMS is surgery, which must be
designed to be curative. Adjuvant radiotherapy or che-
motherapy may be used for control of local recurrence
in case of positive surgical margins, high-grade or large
tumors.
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